The amended Company Law of China (the New Company Law) took effect on July 1, 2024, making substantial changes to existing rules in a wide range of areas including, among others, new timeline requirements for capital...more
As of November 1, 2024, China has officially implemented the beneficiary owner information (BOI) filing requirements for all business entities in the country following the effectiveness of the Administrative Measures on...more
Inventive deal structures are on the rise within China’s life sciences industry, with the “NewCo” model having garnered significant interest among Chinese pharmaceutical companies in recent years. In 2024, several landmark...more
In recent years, China has introduced significant changes to its Drug Administration Law and corresponding legislation, including the nationwide Market Authorization Holder (MAH) system. These reforms aim to boost foreign...more
Beginning November 7, 2023, the Apostille Convention of the Hague Conference on Private International Law will come into effect in mainland China. Upon effectiveness, the country will replace the current legalization process...more
China’s Ministry of Science and Technology (MOST) officially announced on June 1, 2023 the release of the “Detailed Implementation Rules for the Management Regulations of Human Genetic Resources” (the Detailed HGR Rules)....more
6/6/2023
/ Biotechnology ,
China ,
Compliance ,
Export Controls ,
Genetic Materials ,
Genetic Testing ,
Healthcare ,
Life Sciences ,
Multinationals ,
Pharmaceutical Industry ,
Popular